• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.直径≤1厘米的甲状腺结节与甲状腺微小乳头状癌:巴西专家意见
Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. doi: 10.20945/2359-3997000000166. eCollection 2019.
2
Is fine needle aspiration really not necessary in patients with thyroid nodules ≤ 1 cm with highly suspicious features on ultrasonography and candidates for active surveillance?对于超声检查有高度可疑特征且适合进行主动监测的甲状腺结节≤1cm的患者,细针穿刺真的没有必要吗?
Diagn Cytopathol. 2017 Apr;45(4):294-296. doi: 10.1002/dc.23673. Epub 2017 Feb 20.
3
The role of BRAFV600E mutation and ultrasonography for the surgical management of a thyroid nodule suspicious for papillary thyroid carcinoma on cytology.BRAFV600E 突变和超声检查在细胞学检查提示甲状腺乳头状癌可疑的甲状腺结节手术管理中的作用。
Ann Surg Oncol. 2009 Nov;16(11):3125-31. doi: 10.1245/s10434-009-0644-9. Epub 2009 Jul 31.
4
Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management.超声测量的甲状腺结节大小与大体病理检查结果的一致性:对患者管理的影响。
Diagn Cytopathol. 2007 Sep;35(9):579-83. doi: 10.1002/dc.20714.
5
Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.应用手动宏观切割选择甲状腺乳头状微小癌细胞行细针穿刺细胞学检查以检测 BRAF(V600E) 突变:提高术前诊断的有效工具。
Thyroid. 2012 Mar;22(3):292-8. doi: 10.1089/thy.2011.0107. Epub 2011 Dec 19.
6
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.ACR TI-RADS 与 ATA US 评分有助于对具有不确定细胞学特征的甲状腺结节进行管理。
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
7
Management of Sonographically Suspicious Thyroid Nodules 1 cm or Smaller and Candidacy for Active Surveillance: Experience of a Tertiary Center in China.中国一家三级中心在超声检查可疑 1cm 或更小的甲状腺结节和主动监测候选者方面的管理经验。
Endocr Pract. 2021 Sep;27(9):903-911. doi: 10.1016/j.eprac.2021.02.006. Epub 2021 Feb 17.
8
The combined role of ultrasound and frozen section in surgical management of thyroid nodules read as suspicious for papillary thyroid carcinoma on fine needle aspiration biopsy: a retrospective study.超声与冰冻切片在细针穿刺活检提示为甲状腺乳头状癌可疑的甲状腺结节手术管理中的联合作用:一项回顾性研究
World J Surg. 2009 May;33(5):950-7. doi: 10.1007/s00268-009-9984-7.
9
Validation of American Thyroid Association Ultrasound Risk Assessment of Thyroid Nodules Selected for Ultrasound Fine-Needle Aspiration.美国甲状腺协会超声评估甲状腺结节细针抽吸术适应证的验证。
Thyroid. 2017 Aug;27(8):1077-1082. doi: 10.1089/thy.2016.0555. Epub 2017 Jul 18.
10
The anteroposterior diameter of nodules in the risk assessment of papillary thyroid microcarcinoma.甲状腺微小乳头状癌风险评估中结节的前后径
Medicine (Baltimore). 2018 Mar;97(10):e9712. doi: 10.1097/MD.0000000000009712.

引用本文的文献

1
Active surveillance versus immediate surgery in the management of low-risk papillary thyroid microcarcinoma: comparison of long-term costs in Brazil.主动监测与即刻手术治疗低危型甲状腺微小乳头状癌:巴西长期成本比较。
Arch Endocrinol Metab. 2024 Jul 12;68:e230349. doi: 10.20945/2359-4292-2023-0349. eCollection 2024.
2
Impact of a simple informative leaflet on Brazilian doctors' attitudes towards active surveillance of thyroid microcarcinomas.一份简单的信息传单对巴西医生关于甲状腺微小癌主动监测态度的影响。
Heliyon. 2024 Sep 2;10(17):e37300. doi: 10.1016/j.heliyon.2024.e37300. eCollection 2024 Sep 15.
3
The predictive models based on multimodality ultrasonography for the differential diagnosis of thyroid nodules smaller than 10 mm.基于多模态超声的甲状腺结节小于 10mm 的鉴别诊断预测模型。
Br J Radiol. 2023 Sep;96(1149):20221120. doi: 10.1259/bjr.20221120. Epub 2023 Jul 5.
4
Guidelines from the Brazilian society of surgical oncology regarding indications and technical aspects of neck dissection in papillary, follicular, and medullary thyroid cancers.巴西外科肿瘤学会关于甲状腺乳头、滤泡和髓样癌颈部清扫术适应证和技术方面的指南。
Arch Endocrinol Metab. 2023 May 12;67(4):e000607. doi: 10.20945/2359-3997000000607.
5
Treatment strategies for low-risk papillary thyroid carcinoma: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).低危型甲状腺乳头状癌的治疗策略:巴西内分泌学会甲状腺分会的立场声明。
Arch Endocrinol Metab. 2022;66(4):522-532. doi: 10.20945/2359-3997000000512.
6
Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.甲状腺细胞学不确定结节的分子检测:一项卫生技术评估。
Ont Health Technol Assess Ser. 2022 Apr 1;22(2):1-111. eCollection 2022.
7
Different Threshold of Malignancy for -like Thyroid Tumors Causes Significant Differences in Thyroid Nodule Practice.甲状腺样肿瘤不同的恶性阈值导致甲状腺结节诊疗存在显著差异。
Cancers (Basel). 2022 Feb 5;14(3):812. doi: 10.3390/cancers14030812.
8
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.成人非家族性滤泡上皮来源甲状腺癌的分子病理学:从 RAS/BRAF 样肿瘤分类到分子风险分层。
Endocr Pathol. 2021 Mar;32(1):44-62. doi: 10.1007/s12022-021-09666-1. Epub 2021 Mar 2.
9
Active surveillance for low-risk small papillary thyroid cancer in North American countries: past, present and future (bridging the gap between North American and Asian practices).北美国家对低风险小乳头状甲状腺癌的主动监测:过去、现在与未来(弥合北美与亚洲实践之间的差距)
Gland Surg. 2020 Oct;9(5):1685-1697. doi: 10.21037/gs-20-389.
10
Active surveillance of thyroid microcarcinomas.甲状腺微小癌的主动监测。
Arch Endocrinol Metab. 2019 Oct 10;63(5):454-455. doi: 10.20945/2359-3997000000181. eCollection 2019.

本文引用的文献

1
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.韩国多中心队列研究:低危甲状腺微小乳头状癌的主动监测。
Thyroid. 2018 Dec;28(12):1587-1594. doi: 10.1089/thy.2018.0263. Epub 2018 Oct 17.
2
Active Surveillance in Thyroid Microcarcinoma in a Latin-American Cohort.拉丁美洲队列中甲状腺微小癌的主动监测。
JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):947-948. doi: 10.1001/jamaoto.2018.1663.
3
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.意大利分化型甲状腺癌诊断和治疗共识:六个意大利学会的联合声明。
J Endocrinol Invest. 2018 Jul;41(7):849-876. doi: 10.1007/s40618-018-0884-2. Epub 2018 May 4.
4
Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma.超声引导经皮微波消融与手术治疗甲状腺微小乳头状癌的比较。
Int J Hyperthermia. 2018 Aug;34(5):653-659. doi: 10.1080/02656736.2018.1453092. Epub 2018 Apr 11.
5
Prediction of Cancer Incidence and Mortality in Korea, 2018.2018 年韩国癌症发病率与死亡率预测。
Cancer Res Treat. 2018 Apr;50(2):317-323. doi: 10.4143/crt.2018.142. Epub 2018 Mar 21.
6
Percutaneous Laser Ablation of Unifocal Papillary Thyroid Microcarcinoma: Utility of Conventional Ultrasound and Contrast-Enhanced Ultrasound in Assessing Local Therapeutic Response.经皮激光消融治疗单灶性甲状腺微小乳头状癌:传统超声和超声造影在评估局部治疗反应中的应用
World J Surg. 2018 Aug;42(8):2476-2484. doi: 10.1007/s00268-018-4500-6.
7
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.高血清促甲状腺激素水平与甲状腺微小乳头状癌主动监测期间的进展相关。
J Clin Endocrinol Metab. 2018 Feb 1;103(2):446-451. doi: 10.1210/jc.2017-01775.
8
European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS.欧洲甲状腺协会成人甲状腺结节超声恶性风险分层指南:欧盟甲状腺影像报告和数据系统(EU-TIRADS)
Eur Thyroid J. 2017 Sep;6(5):225-237. doi: 10.1159/000478927. Epub 2017 Aug 8.
9
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.甲状腺乳头状癌在主动监测期间的自然病史和肿瘤体积动力学
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.
10
Ethanol and thermal ablation for malignant thyroid tumours.乙醇和热消融治疗甲状腺恶性肿瘤。
Int J Hyperthermia. 2017 Dec;33(8):938-945. doi: 10.1080/02656736.2017.1361048. Epub 2017 Aug 11.

直径≤1厘米的甲状腺结节与甲状腺微小乳头状癌:巴西专家意见

Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.

作者信息

Rosario Pedro Weslley, Ward Laura Sterian, Graf Hans, Vaisman Fernanda, Mourão Gabriela Franco, Vaisman Mario

机构信息

Santa Casa de Belo Horizonte, Minas Gerais, MG, Brasil.

Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), São Paulo, SP, Brasil.

出版信息

Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. doi: 10.20945/2359-3997000000166. eCollection 2019.

DOI:10.20945/2359-3997000000166
PMID:31482953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10522266/
Abstract

The indolent evolution of low-risk papillary thyroid microcarcinoma (mPTC) in adult patients and the consequences of thyroidectomy require a revision of the management traditionally recommended. Aiming to spare patients unnecessary procedures and therapies and to optimize the health system in Brazil, we suggest some measures. Fine-needle aspiration of nodules ≤ 1 cm without extrathyroidal extension on ultrasonography should be performed only in nodules classified as "very suspicious" (i.e., high suspicion according to ATA, high risk according to AACE, TI-RADS 5) and in selected cases [age < 40 years, nodule adjacent to the trachea or recurrent laryngeal nerve (RLN), multiple suspicious nodules, presence of hypercalcitoninemia or suspicious lymph nodes]. Active surveillance (AS) rather than immediate surgery should be considered in adult patients with low-risk mPTC. Lobectomy is the best option in patients with unifocal low-risk mPTC who are not candidates for AS because of age, proximity of the tumor to the trachea or RLN, or because they opted for surgery. The same applies to patients who started AS but had a subsequent surgical indication not due to a suspicion of tumor extension beyond the gland or multicentricity. Molecular tests are not necessary to choose between AS and surgery or, in the latter case, between lobectomy and total thyroidectomy. The presence of RAS or other RAS-like mutations or BRAFV600E or other BRAF V600E-like mutations should not modify the management cited above; however, the rare cases of mPTC exhibiting high-risk mutations, like in the TERT promoter or p53, are not candidates for AS.

摘要

成年患者中低风险甲状腺微小乳头状癌(mPTC)的惰性进展以及甲状腺切除的后果,需要对传统推荐的管理方法进行修订。为了避免患者接受不必要的手术和治疗,并优化巴西的医疗体系,我们提出一些措施。对于超声检查显示直径≤1 cm且无甲状腺外侵犯的结节,仅应对分类为“高度可疑”(即根据美国甲状腺协会为高可疑,根据美国临床内分泌医师协会为高风险,TI-RADS 5类)的结节以及特定情况(年龄<40岁、结节紧邻气管或喉返神经(RLN)、多个可疑结节、存在降钙素血症或可疑淋巴结)进行细针穿刺。对于低风险mPTC的成年患者,应考虑采取主动监测(AS)而非立即手术。对于因年龄、肿瘤与气管或RLN的距离等原因不适合AS或选择手术的单灶低风险mPTC患者,肺叶切除术是最佳选择。对于开始AS但随后出现手术指征(并非怀疑肿瘤超出腺体或多中心性)的患者也是如此。在选择AS与手术之间,或者在后一种情况下,在肺叶切除术与全甲状腺切除术之间,分子检测并非必需。RAS或其他类似RAS的突变、BRAFV600E或其他类似BRAF V600E的突变的存在不应改变上述管理方法;然而,mPTC中表现出高风险突变(如TERT启动子或p53中的突变)的罕见病例不适合AS。